Cigna Corp. will not cover My­lan’s EpiPen epinephrine au­toin­jec­tor in 2017.

Modern Healthcare - - LATE NEWS -

In­stead, the in­surer will cover My­lan’s $300 generic ver­sion of the EpiPen, which is half the list price of the brand-name drug. Cigna’s switch to the re­cently launched My­lan generic comes a day af­ter Pres­i­dent-elect Trump said many drug com­pa­nies are “get­ting away with mur­der” set­ting their prod­ucts’ prices. CVS Health re­ported that it would sell the au­tho­rized generic ver­sion of Adrenaclick, a less-pre­scribed al­ter­na­tive to the EpiPen. CVS will sell the generic ver­sion of Adrenaclick for $109.99 per twopack for both in­sured and unin­sured pa­tients—about one­fifth the list price of the brand­name EpiPen.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.